Abstract
Introduction and scale-up of new contraceptive technologies, including the subcutaneous injectable DMPA (DMPA-SC, or Sayana® Press* ), can dramatically expand access and options for women and adolescent girls. The process tends to follow four stages: initiation, preparation, introduction, and integration.
